about
Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?Positron Emission Tomography (PET) in OncologyEPMA position paper in cancer: current overview and future perspectives.Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapyDevelopment of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesionsHealth behaviors and quality of life in Chinese survivors of cervical cancer: a retrospective study.Brachytherapy in cancer cervix: Time to move ahead from point A?Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer.Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.Prognostic value of posttreatment F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameterCombined pretreatment with F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial
P2860
Q34180901-B2E9F3ED-546E-4B11-8FAE-778FC70B8047Q34774840-BEF4DD6D-FD87-46A1-A2E4-54C63B4F7D5CQ35532215-C9C0198D-712C-4ED1-B9F1-1CE436935CF6Q35945537-54644A03-772A-4F79-B6EA-C6FD88761ECCQ36014483-C9368FB1-FE3D-4A07-B722-48D011D3407CQ36609751-DCAFD98D-311B-4CD3-ADDA-0789A1347332Q36691460-046B3C94-CC50-48DC-82B9-574069550344Q37511930-E9D438A4-96FF-4863-9346-D5725D49FFDDQ37729734-AAFA56F3-4F51-49AA-851C-408F766B17E8Q38258755-D2EAB52D-E609-4568-A0CC-27EA0A05575AQ47582480-D3539EAB-7E71-4AAE-AC2F-AEDF1AE0DC1FQ47668675-BFD64447-996A-422A-A98E-30FA8F68D045Q47692196-C8C05757-AC9F-4911-910A-8B1DEC4FDCA1Q49845473-6CC8FD31-7493-4CCB-92A9-A8D47EE30E96Q50003350-7B8313E1-9106-4409-A647-657A42F2D7C6Q56349857-5ACC7EBA-34DF-4A57-94D6-36125F91FE2EQ58801380-7AD87923-074F-4FD1-BD63-DF41EFCF9FA2
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The role of PET/CT in cervical cancer
@ast
The role of PET/CT in cervical cancer
@en
type
label
The role of PET/CT in cervical cancer
@ast
The role of PET/CT in cervical cancer
@en
prefLabel
The role of PET/CT in cervical cancer
@ast
The role of PET/CT in cervical cancer
@en
P2860
P356
P1476
The role of PET/CT in cervical cancer
@en
P2093
Fernanda G Herrera
P2860
P356
10.3389/FONC.2013.00034
P577
2013-02-26T00:00:00Z